Cancers Treated by MRIdian

In 8 years, nearly 27,000 patients, and more than 67 disease types have been treated with the lifesaving technology clinically developed to target tumors, shape the dose, and strike with accurate precision. MRIdian is the only radiotherapy solution with real-time tissue tracking and automated beam gating, representing a new paradigm in radiation oncology. 

 

MRIdian offers advanced MRI-guided radiation therapy to patients who are seeking personalized treatment for pancreas, prostate, lung, liver, breast, and oligometastatic cancers.

 

Learn how patients with cancers of all types are benefiting from non-invasive, surgical-like capabilities that give physicians the confidence to target tumors in real-time and treat them with tighter margins, higher doses, and fewer fractions, all with low toxicity.7

Locate a MRIdian system treatment center near you.

MRIdian allows oncologists to visualize, adapt, and target using anatomical detail that
is simply unavailable with conventional IGRT technologies.